Testing effectiveness (Phase 2)WithdrawnNCT02424513
What this trial is testing
Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer
Who this might be right for
Prostate Cancer
ImaginAb, Inc.
Showing 20 of 0 results